Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
Year: 2003
Type: article
Source: PubMed
Language: English
Subfield: Physiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2120151913
